Cooley advises in pharmaceutical merger
Palo Alto-based Jazz Pharmaceuticals Inc. turned to Cooley LLP for its merger with Ireland-based Azur Pharma Ltd. The combined company is expected to generate annual revenues of more than $475 million. Palo Alto partner Suzanne Sawochka Hooper led the Cooley team with Palo Alto partners Jennifer Fonner DiNucci, Chadwick L. Mills, Barbara A. Kosacz, Mark Winfeld-Hansen, We...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In